H.C. Wainwright Affirms Buy Rating for ImmunityBio, Inc. (IBRX) Following Promising Bladder Cancer Treatment Results

In a significant development for the field of oncology, ImmunityBio, Inc. (NASDAQ: IBRX) has recently announced positive results from its clinical trials focused on treating bladder cancer. This ...

HC Wainwright asserts buy stance as ImmunityBio, Inc. (IBRX) achieves positive results on bladder cancer treatment

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.
pharmaphorum

ImmunityBio rises as route opens to broader Anktiva label

Shares in ImmunityBio rose sharply after the company said it has agreed a path with the FDA that will allow it to refile for ...
STAT

Bladder cancer treatment landscape is advancing, at last

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...
Everyday Health on MSN

How to protect your kidney health if you have metastatic bladder cancer

If you have metastatic bladder cancer, you may also be at higher risk for kidney problems, including acute kidney injuries ...
Black Enterprise

Post Bladder Cancer, Deion Sanders Will ‘Depend On Depend’ In New Partnership With Adult Diaper Brand

The news comes shortly after Sanders revealed he had his bladder removed due to a cancer diagnosis. In a timely announcement, Depend adult underwear has revealed its partnership with Deion Sanders ...

ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA(R) in BCG-Unresponsive Papillary Bladder Cancer

Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its evaluation of this information to potentially support a resubmission of the sBLA ...